The World Health Organization (WHO) on Wednesday recommended against using generic antiparasite drug ivermectin in patients with COVID19 except for clinical trials, because of a lack of data demonstrating its benefits.
WHO Joins Europe, Merck in Recommending Against Ivermectin for Covid-19
-
Unicaus News
- . March 31, 2021
